Channel Therapeutics Corporation Watch

from 8-K12G3 21 pages Channel Therapeutics Corporation Indemnification Agreement

from 8-K 21 pages Channel Therapeutics Corporation Indemnification Agreement

from 10-Q 1 page Second Amendment to the Chromocell Therapeutics Corporation 2023 Equity Incentive Plan as Adopted by Resolution of the Board of Directors Effective as of June 12, 2024

from 8-K 29 pages Registration Rights Agreement

from 8-K 70 pages Common Stock Purchase Agreement Dated as of July 26, 2024 by and Between Chromocell Therapeutics Corporation and Tikkun Capital LLC

from 8-K 69 pages Securities Purchase Agreement

from 10-Q 11 pages Employment Agreement

from 10-Q 5 pages Chromocell Therapeutics Corporation Promissory Note

from 10-Q 4 pages Re: Amended and Restated Consultant Agreement

from S-1/A 28 pages Development and License Agreement by and Between Benuvia Operations, LLC and Chromocell Therapeutics Corp. Development and License Agreement

from S-1/A 4 pages Dominion Capital LLC 256 W. 38th Street, 15th Floor New York, Ny 10018 Re: Securities Purchase Agreement 1. Pursuant to Section 2.5(a) of the Securities Purchase Agreement, the Company Hereby Waives Purchaser’s Obligation to Fund the Subscription Amount in Full, and the Company Shall Have No Obligation to Issue Preferred Stock to Purchaser. 2. Pursuant to Section 2.5(b) of the Securities Purchase Agreement, the Company Shall Continue to Have the Obligation to Issue the Full Amount of the Standby Shares Upon the Close of the Initial Public Offering. 3. the Parties Therefore Agree to Terminate Each of Their Obligations Solely With Respect to the Preferred Stock Under the Securities Purchase Agreement and the Registration Rights Agreement, Effective November 13, 2023

from S-1/A 18 pages Registration Rights Agreement

from S-1/A 39 pages Securities Purchase Agreement

from S-1/A 66 pages Securities Purchase Agreement

from S-1/A 1 page First Amendment to the Chromocell Therapeutics Corporation 2023 Equity Incentive Plan as Adopted by Resolution of the Board of Directors Effective as of [September __, 2023]

from S-1/A 15 pages Form of Registration Rights Agreement

from S-1/A 12 pages Form of Securities Purchase Agreement

from S-1/A 34 pages Security Agreement

from S-1/A 65 pages Securities Purchase Agreement

from S-1/A 11 pages Chromocell Therapeutics Corporation Amended and Restated Employment Agreement